Lay-offs follow suspension of clinical trials of protein.
M
M
Verrall
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy; D000818:Animals; D017326:Clinical Trials, Phase III as Topic / Q000191:economics; D004345:Drug Industry / Q000191:economics*; D004651:Employment; D006801:Humans; D009414:Nerve Growth Factors / Q000009:adverse effects / Q000627:therapeutic use*; D009419:Nerve Tissue Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D000078329:Workforce
D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins